BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

274 related articles for article (PubMed ID: 16564763)

  • 1. Clinical trials of uric acid lowering for coronary heart disease risk reduction.
    Simon JA
    Am J Med; 2006 Apr; 119(4):e5; author reply e7. PubMed ID: 16564763
    [No Abstract]   [Full Text] [Related]  

  • 2. [Serum uric acid--a cardiovasular risk factor?].
    Alderman M; Redfern JS
    Ther Umsch; 2004 Sep; 61(9):547-52. PubMed ID: 15493113
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Drugs in the treatment of hyperuricemia.
    Elion GB
    Adv Nephrol Necker Hosp; 1974; 3():51-7. PubMed ID: 4219708
    [No Abstract]   [Full Text] [Related]  

  • 4. [Hyperuricemia].
    Chizyński K; Rózycka M
    Pol Merkur Lekarski; 2005 Nov; 19(113):693-6. PubMed ID: 16498814
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of uric acid-lowering therapy on the progression of chronic kidney disease: a systematic review and meta-analysis.
    Liu X; Zhai T; Ma R; Luo C; Wang H; Liu L
    Ren Fail; 2018 Nov; 40(1):289-297. PubMed ID: 29619870
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum uric acid and the risk of hypertension and chronic kidney disease.
    Feig DI
    Curr Opin Rheumatol; 2014 Mar; 26(2):176-85. PubMed ID: 24419747
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Letter by George regarding article, "Uric acid-lowering treatment with benzbromarone in patients with heart failure: a double-blind placebo-controlled cross-over preliminary study".
    George J
    Circ Heart Fail; 2010 May; 3(3):e10; author reply e14. PubMed ID: 20484184
    [No Abstract]   [Full Text] [Related]  

  • 8. [Uric acid 8.4 in an asymptomatic patient. Does he need medication?].
    Füessl HS
    MMW Fortschr Med; 2012 Jun; O 154 Suppl 2():22. PubMed ID: 22916420
    [No Abstract]   [Full Text] [Related]  

  • 9. The treatment of hyperuricemia.
    Lowenthal DT
    Am Fam Physician; 1976 Jul; 14(1):98-100. PubMed ID: 937167
    [No Abstract]   [Full Text] [Related]  

  • 10. [Use of anturan in patients with ischemic heart disease with a history of acute myocardial infarction].
    Bokarev IN; Golikov AP; Liusov VA; Ptushkin VV; Zvereva TV
    Klin Med (Mosk); 1987 Oct; 65(10):29-32. PubMed ID: 3431051
    [No Abstract]   [Full Text] [Related]  

  • 11. [Drug-induced hypouricemia: pathophysiology and application to the hyperuricemia with life style related disease].
    Hisatome I; Ogino K; Igawa O; Shigemasa C
    Nihon Rinsho; 2003 Jan; 61 Suppl 1():403-9. PubMed ID: 12629757
    [No Abstract]   [Full Text] [Related]  

  • 12. [Platelet aggregation inhibitors in the prevention of myocardial infarction: the results of prospective studies].
    Shalaev SV
    Kardiologiia; 1989 Sep; 29(9):116-20. PubMed ID: 2687554
    [No Abstract]   [Full Text] [Related]  

  • 13. Status of uric acid management in hypertensive subjects.
    Yamamoto Y; Matsubara K; Igawa G; Kaetsu Y; Sugihara S; Matsuura T; Ando F; Sonoyama K; Hamada T; Ogino K; Igawa O; Shigemasa C; Hisatome I
    Hypertens Res; 2007 Jun; 30(6):549-54. PubMed ID: 17664859
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The internal therapy of patients with uric acid containing urinary calculi].
    Zöllner N
    Urologe; 1968; 7(1):46-50. PubMed ID: 5667553
    [No Abstract]   [Full Text] [Related]  

  • 15. [Should asymptomatic hyperuricemia be treated?].
    Gerster JC
    Rev Med Suisse Romande; 1983 May; 103(5):457-60. PubMed ID: 6878975
    [No Abstract]   [Full Text] [Related]  

  • 16. [Uricosuric agents: Should they be used in asymptomatic hyperuricemia?].
    Naess K
    Tidsskr Nor Laegeforen; 1976 Jan; 96(1):45-6. PubMed ID: 1257956
    [No Abstract]   [Full Text] [Related]  

  • 17. Role of platelet-active drugs in coronary artery disease.
    Sherry S
    Cardiovasc Clin; 1983; 14(1):173-89. PubMed ID: 6352025
    [No Abstract]   [Full Text] [Related]  

  • 18. Clinical experiences with Milurit treatment in uricacidemia of various origin.
    Raderecht C; Schäfer C
    Ther Hung; 1975; 23(1):32-6. PubMed ID: 1105873
    [No Abstract]   [Full Text] [Related]  

  • 19. Uric acid and oxidative stress: relative impact on cardiovascular risk?
    Strazzullo P; Puig JG
    Nutr Metab Cardiovasc Dis; 2007 Jul; 17(6):409-14. PubMed ID: 17643880
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Potential mechanisms of stroke benefit favoring losartan in the Losartan Intervention For Endpoint reduction in hypertension (LIFE) study.
    Devereux RB; Dahlöf B
    Curr Med Res Opin; 2007 Feb; 23(2):443-57. PubMed ID: 17288698
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.